Xcell Therapeutics Inc. (KOSDAQ:373110)

Xcell Therapeutics Statistics

Total Valuation

KOSDAQ:373110 has a market cap or net worth of KRW 25.44 billion. The enterprise value is 30.59 billion.

Market Cap	25.44B
Enterprise Value	30.59B

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:373110 has 17.29 million shares outstanding. The number of shares has increased by 14.60% in one year.

Current Share Class	17.29M
Shares Outstanding	17.29M
Shares Change (YoY)	+14.60%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	12.68%
Owned by Institutions (%)	3.55%
Float	13.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.68
PB Ratio	15.68
P/TBV Ratio	28.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.06
EV / Sales	22.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.30

Financial Position

The company has a current ratio of 0.68, with a Debt / Equity ratio of 3.93.

Current Ratio	0.68
Quick Ratio	0.30
Debt / Equity	3.93
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -154.65% and return on invested capital (ROIC) is -50.15%.

Return on Equity (ROE)	-154.65%
Return on Assets (ROA)	-42.33%
Return on Invested Capital (ROIC)	-50.15%
Return on Capital Employed (ROCE)	-210.86%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	2.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-63.18%
50-Day Moving Average	1,670.00
200-Day Moving Average	2,722.36
Relative Strength Index (RSI)	36.27
Average Volume (20 Days)	110,801

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:373110 had revenue of KRW 1.36 billion and -10.01 billion in losses. Loss per share was -915.30.

Revenue	1.36B
Gross Profit	-1.51B
Operating Income	-10.10B
Pretax Income	-10.01B
Net Income	-10.01B
EBITDA	-8.39B
EBIT	-10.10B
Loss Per Share	-915.30

Balance Sheet

The company has 1.22 billion in cash and 6.37 billion in debt, with a net cash position of -5.15 billion or -297.59 per share.

Cash & Cash Equivalents	1.22B
Total Debt	6.37B
Net Cash	-5.15B
Net Cash Per Share	-297.59
Equity (Book Value)	1.62B
Book Value Per Share	148.29
Working Capital	-1.82B

Cash Flow

In the last 12 months, operating cash flow was -8.37 billion and capital expenditures -902.07 million, giving a free cash flow of -9.27 billion.

Operating Cash Flow	-8.37B
Capital Expenditures	-902.07M
Free Cash Flow	-9.27B
FCF Per Share	-536.20

Margins

Gross Margin	-110.99%
Operating Margin	-741.13%
Pretax Margin	-734.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:373110 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.60%
Shareholder Yield	-14.60%
Earnings Yield	-39.35%
FCF Yield	-36.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:373110 has an Altman Z-Score of -8.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.63
Piotroski F-Score	2